Senores Pharmaceuticals Limited has entered into the Share Purchase Agreement (SPA) with certain shareholders (Public Category) of Havix Group. D/B/A Aavis Pharmaceuticals (Havix) for acquisition of 8,454 equity shares of Havix aggregating to 3.73% of the total paid up share capital of Havix and subject to the terms and conditions as mentioned in the SPA

Further, post the aforesaid acquisition, the shareholding of the Company in Havix will increase from 51.23% to 54.96%.

Havix was incorporated under the laws of the State of Delaware on February 17, 2015. Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations. The turnover of Havix for the financial year ended March 31, 2024 was US$ 14,440,414.